As the robotics industry accelerates its transition toward large-scale commercialization, Shoucheng Holdings (0697.HK) has announced another significant milestone in its robotics investment and ...

Krystal Biotech is upgraded to Strong Buy as Vyjuvek sales surge and catalysts build. Click here to know more.

Incyte Corporation is rated Strong Buy with recent execution driving a 56% stock rally and robust revenue growth. Learn more ...

True patient-centricity will drive commercial success as CGT moves beyond first-generation therapies. Current timelines in CGT, from diagnosis to treatment, can exceed six months, often compounded by ...

What is noise and what drives real performance in innovation investing? Only four strategies consistently explain venture ...

NEW YORK, NY / ACCESS Newswire / January 7, 2026 / The Glimpse Group, Inc. ("Glimpse") (NASDAQ:VRAR), a diversified Immersive ...

The cricket analysis software market is expanding due to rising investments in cricket leagues, growth of T20 and ...

Continued strong growth of ZORYVE® (roflumilast) in 2026 with full-year net product sales guidance of $455-$470 millionAdvancement of ZORYVE indication-expansion strategy beginning with ongoing Phase ...

Quantum Transportation holds an exclusive sub license, for rail technologies and platforms, for an innovative pending patent application in quantum error correction owned by Ramot, the technology ...

Key opportunities in the orbital transport services market include the rise of mega-constellation deployments, demand for ...

As Vietnam moves into 2026, Party General Secretary To Lam has laid out a bold roadmap for the nation’s digital and technological transformation, calling for decisive execution and real-world outcomes ...

COPENHAGEN, Denmark, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today provided a business and strategic roadmap update, including planned 2026 key corporate milestones.